Seminal Vesicles
-
Subject Areas on Research
- 111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.
- A comparison of coplanar four-field techniques for conformal radiotherapy of the prostate.
- Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted?
- An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer.
- Androgen-independent prostate cancer progression in the TRAMP model.
- Arc-modulated radiation therapy based on linear models.
- Atlas-guided prostate intensity modulated radiation therapy (IMRT) planning.
- Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
- DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.
- Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
- Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
- Dynamic prediction of metastases after radical prostatectomy for prostate cancer.
- Editorial Comment.
- Editorial Comment.
- Enteric type adenocarcinoma of the upper tract urothelium associated with ectopic ureter and renal dysplasia: an oncological rationale for complete extirpation of this aberrant developmental anomaly.
- Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
- Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
- Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers.
- Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy.
- Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
- Normal prostate and adjacent structures: MR imaging at 1.5 T.
- Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule.
- Prostatic disorders: MR imaging at 1.5 T.
- Quantification of prostate and seminal vesicle interfraction variation during IMRT.
- Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
- Re: Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain.
- Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study.
- Seminal vesiculography: limited value in vesiculitis.
- Similarities between static and rotational intensity-modulated plans.
- Simplified technique for vasography.
- Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
- Testicular adenosine 3':5'-monophosphate-dependent protein kinase. Regulation by follicle-stimulating hormone.
- The reversible antifertility effect of Piper betle Linn. on Swiss albino male mice.
- The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer.
- The role of seminal vesiculography in the evaluation of male infertility.
- Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase.
- Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain.
- Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy.
- Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer.
-
Keywords of People
- O'Daniel, Jennifer Colleen, Assistant Professor of Radiation Oncology, Radiation Oncology
- Yoo, Sua, Associate Professor of Radiation Oncology, Radiation Oncology